These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

818 related articles for article (PubMed ID: 19684190)

  • 21. Melatonin Receptor Agonist Ramelteon Reduces Ischemia-Reperfusion Injury Through Activation of Mitochondrial Potassium Channels.
    Stroethoff M; Christoph I; Behmenburg F; Raupach A; Bunte S; Senpolat S; Heinen A; Hollmann MW; Mathes A; Huhn R
    J Cardiovasc Pharmacol; 2018 Aug; 72(2):106-111. PubMed ID: 29787401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temperature preconditioning of isolated rat hearts--a potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore.
    Khaliulin I; Clarke SJ; Lin H; Parker J; Suleiman MS; Halestrap AP
    J Physiol; 2007 Jun; 581(Pt 3):1147-61. PubMed ID: 17395631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nigella sativa attenuates myocardial ischemic reperfusion injury in rats.
    Seif AA
    J Physiol Biochem; 2013 Dec; 69(4):937-44. PubMed ID: 23846789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart.
    Javadov SA; Clarke S; Das M; Griffiths EJ; Lim KH; Halestrap AP
    J Physiol; 2003 Jun; 549(Pt 2):513-24. PubMed ID: 12692185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart.
    Di Lisa F; Menabò R; Canton M; Barile M; Bernardi P
    J Biol Chem; 2001 Jan; 276(4):2571-5. PubMed ID: 11073947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased susceptibility to Ca(2+)-induced permeability transition and to cytochrome c release in rat heart mitochondria with aging: effect of melatonin.
    Petrosillo G; Moro N; Paradies V; Ruggiero FM; Paradies G
    J Pineal Res; 2010 May; 48(4):340-6. PubMed ID: 20345745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of melatonin on oncosis of myocardial cells in the myocardial ischemia/reperfusion injury rat and the role of the mitochondrial permeability transition pore.
    Liu LF; Qian ZH; Qin Q; Shi M; Zhang H; Tao XM; Zhu WP
    Genet Mol Res; 2015 Jul; 14(3):7481-9. PubMed ID: 26214427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingosine 1-Phosphate Postconditioning Protects Against Myocardial Ischemia/reperfusion Injury in Rats via Mitochondrial Signaling and Akt-Gsk3β Phosphorylation.
    Fang R; Zhang LL; Zhang LZ; Li W; Li M; Wen K
    Arch Med Res; 2017 Feb; 48(2):147-155. PubMed ID: 28625317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A.
    Onishi A; Miyamae M; Kaneda K; Kotani J; Figueredo VM
    Eur J Pharmacol; 2012 Jan; 675(1-3):40-6. PubMed ID: 22166375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin inhibits cardiolipin peroxidation in mitochondria and prevents the mitochondrial permeability transition and cytochrome c release.
    Petrosillo G; Moro N; Ruggiero FM; Paradies G
    Free Radic Biol Med; 2009 Oct; 47(7):969-74. PubMed ID: 19577639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial bioenergetics and cardiolipin alterations in myocardial ischemia-reperfusion injury: implications for pharmacological cardioprotection.
    Paradies G; Paradies V; Ruggiero FM; Petrosillo G
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1341-H1352. PubMed ID: 30095969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo.
    Pagel PS; Krolikowski JG; Shim YH; Venkatapuram S; Kersten JR; Weihrauch D; Warltier DC; Pratt PF
    Anesth Analg; 2007 Sep; 105(3):562-9. PubMed ID: 17717207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Activation of mitochondrial aldehyde dehydrogenase 2 and inhibition of mitochondrial permeability transition pore involved in cardioprotection of ethanol postconditioning].
    Li ZH; Jiang CR; Xia ML; Ye HW; Guan SD; Gao Q
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 39(6):566-71. PubMed ID: 21166048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extent of mitochondrial hexokinase II dissociation during ischemia correlates with mitochondrial cytochrome c release, reactive oxygen species production, and infarct size on reperfusion.
    Pasdois P; Parker JE; Halestrap AP
    J Am Heart Assoc; 2012 Dec; 2(1):e005645. PubMed ID: 23525412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orientin-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
    Lu N; Sun Y; Zheng X
    Planta Med; 2011 Jul; 77(10):984-91. PubMed ID: 21283956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of cytochrome c release by 10-N-nonyl acridine orange, a cardiolipin-specific dye, during myocardial ischemia-reperfusion in the rat.
    Zhang GX; Kimura S; Murao K; Obata K; Matsuyoshi H; Takaki M
    Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H433-9. PubMed ID: 19940077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-associated differences in the inhibition of mitochondrial permeability transition pore opening by cyclosporine A.
    Liu L; Zhu J; Brink PR; Glass PS; Rebecchi MJ
    Acta Anaesthesiol Scand; 2011 May; 55(5):622-30. PubMed ID: 21827445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore.
    Ong SG; Lee WH; Theodorou L; Kodo K; Lim SY; Shukla DH; Briston T; Kiriakidis S; Ashcroft M; Davidson SM; Maxwell PH; Yellon DM; Hausenloy DJ
    Cardiovasc Res; 2014 Oct; 104(1):24-36. PubMed ID: 25063991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tongmai formula improves cardiac function via regulating mitochondrial quality control in the myocardium with ischemia/reperfusion injury.
    Zhao Y; Guo R; Li L; Li S; Fan G; Zhao X; Wang Y
    Biomed Pharmacother; 2020 Dec; 132():110897. PubMed ID: 33113431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
    Hausenloy DJ; Maddock HL; Baxter GF; Yellon DM
    Cardiovasc Res; 2002 Aug; 55(3):534-43. PubMed ID: 12160950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.